✦ LIBER ✦

Endpoints and other considerations in phase I studies of targeted anticancer therapy: Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies (MDICT)

✍ Scribed by Christopher M. Booth; A. Hilary Calvert; Giuseppe Giaccone; Marinus W. Lobbezoo; Lesley K. Seymour; Elizabeth A. Eisenhauer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Design and conduct of phase II studies o

✍ Christopher M. Booth; A. Hilary Calvert; Giuseppe Giaccone; Marinus W. Lobbezoo; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Design and conduct of early clinical stu

✍ Seymour, Lesley K.; Calvert, A. Hilary; Lobbezoo, Marinus W.; Eisenhauer, Elizab 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Phase 0 clinical trials: Recommendations

✍ Shivaani Kummar; James H. Doroshow; Joseph E. Tomaszewski; A. Hilary Calvert; Ma 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Genomics-based early-phase clinical tria

✍ Liu, Stephen V.; Miller, Vincent A.; Lobbezoo, Marinus W.; Giaccone, Giuseppe 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 331 KB